Purity: | 98% |
---|---|
Model Number: | CAS NO.: 57773-63-4 |
Brand Name: | NJBN |
Grade Standard: | |
Type: | Central Nervous System Agents, |
Place of Origin: | China (Mainland) |
MF: | C64H82N18O13 |
Other Names: | MDHT |
CAS No.: | 57773-63-4 |
Quick Details
Specifications
Quick Detail :
CAS | 57773-63-4 |
MF | C64H82N18O13 |
MW | 1311.45 |
Storage temp | below 20°C |
Purity (HPLC) | 98.0% min. |
Appearance | White powder |
Single Impurity (HPLC) | 1.0%max |
Amino Acid Composition | ± 10% of theoretical |
Peptide Content (N%) | ≥ 80.0% |
Water Content(Karl Fischer) | ≤ 6.0% |
Acetate Content (HPIC) | ≤ 15.0% |
Mass Balance | 95.0~105.0% |
Specific Rotation (20/D) | -65.0~-75.0° (c=0.5 1%HAc) |
Delivery/Dispatch time : Within 24h upon the recipt of payment
Description :
Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone and follicle stimulating hormone.
Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.
Application :
Triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.
In the United States, it is sold by Watson as Iran Triptorelin is marketed under the brand name India, Dr. Reddy's Laboratories has launched recently Triptorelin under the brand name "Pamorelin LA". During the treatment of prostate cancer it does cause a surge of testosterone, known as a flare effect. In men a reduction of serum testosterone levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy.
Peptides :
HGH 176-191 2mg/vial 10vials/kit 1g/bag
GHRP-2 5mg/vial 10vials/kit 1g/bag
GHRP-2 10mg/vial 10vials/kit 1g/bag
GHRP-6 5mg/vial 10vials/kit 1g/bag
GHRP-6 10mg/vial 10vials/kit 1g/bag
MGF 2mg/vial 10vials/kit 1g/bag
PEG MGF 2mg/vial 10vials/kit 1g/bag
CJC-1295 with DAC 2mg/vial 10vials/kit 1g/bag
CJC-1295 without DAC 2mg/vial 10vials/kit 1g/bag
PT-141 10mg/vial 10vials/kit 1g/bag
Melanotan-1 10mg/vial 10vials/kit 1g/bag
Melanotan-2 10mg/vial 10vials/kit 1g/bag
Ipamorelin 2mg/vial 10vials/kit 1g/bag
Hexarelin 2mg/vial 10vials/kit 1g/bag
Sermorelin 2mg/vial 10vials/kit 1g/bag
Oxytocin 2mg/vial 10vials/kit 1g/bag
TB500 2mg/vial 10vials/kit 1g/bag
Pentadecapeptide BPC 157 2mg/vial 10vials/kit 1g/bag
Triptorelin 2mg/vial 10vials/kit 1g/bag
Gonadorelin 2mg/vial 10vials/kit 1g/bag
Gonadorelin 10mg/vial 10vials/kit 1g/bag
Tesamorelin 2mg/vial 10vials/kit 1g/bag
DSIP 2mg/vial 10vials/kit 1g/bag
Selank 5mg/vial 10vials/kit 1g/bag